Kedudukan dalam Saham
#29957
INOVIQ Ltd specializes in the research, development, and commercialization of... INOVIQ Ltd specializes in the research, development, and commercialization of diagnostic and exosome-based products, aiming to improve the detection and treatment of cancer and other conditions across Australia and the United States. Its current portfolio includes the hTERT test, an immunocytochemistry assay that serves as a supplementary tool for urine cytology in bladder cancer screening, alongside EXO-NET, designed for the capture and isolation of exosomes from liquid biopsy specimens. The company also boasts a robust diagnostic pipeline, featuring blood tests currently under development for various cancers, including ovarian and breast cancer. Originally incorporated in 1983 and formerly known as BARD1 Life Sciences Limited until its rebranding to INOVIQ Ltd in December 2021, the company maintains its headquarters in Notting Hill, Australia.
Perubahan (1 tahun)
-48.10%
Perdagangan INOVIQ Ltd (IIQ)
Harga IIQ dengan permodalan pasaran b
Modal pasaran bagi INOVIQ Ltd(IIQ)
Modal Pasaran: $18.86M
Sehingga August 2026, INOVIQ Ltd mempunyai modal pasaran sebanyak $18.86M. Ini menjadikan INOVIQ Ltd syarikat ke-29957th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran INOVIQ Ltd dari 1988 hingga 2026
IIQ berbanding dengan 5 teratas yang paling popular stocks
| Harga IIQ |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.307T
|
+28,129,979.45%
|
|
|
|
|
$4.551T
|
+24,123,240.48%
|
|
|
|
|
$4.154T
|
+22,022,099.44%
|
|
|
|
|
$3.589T
|
+19,022,715.86%
|
|
|
|
|
$2.797T
|
+14,825,930.69%
|
